巨病患者的癌症查:呼吁采用个性化方法和国际注册
Luigi Demarchis1,2, Sabrina Chiloiro3,4, Antonella Giampietro1,2
1Dipartimento Di Medicina Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Reviews in endocrine & metabolic disorders
|March 15, 2025
概括
宏壮病患者面临癌症风险增加,新生体取代心血管疾病成为主要死亡原因. 需要进一步的研究和注册,以建立查和管理指南,以发现巨癌症的癌症.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 巨症是一种罕见的疾病,由多余的生长激素引起,与显著的并发病和死亡率有关.
- 心血管疾病是主要的死亡原因,但已被癌症所取代.
- 在壮症中,特定瘤 (结肠,甲状腺,乳腺,前列腺,胃) 的患病率增加需要进一步调查.
研究的目的:
- 为了突出导致死因的转变,从心血管疾病到癌症.
- 强调需要了解将多余生长激素与癌症联系在一起的病原遗传机制.
- 为了确定缺乏关于癌症查和壮病患者风险因素的共识.
主要方法:
- 审查关于壮症并发症和死亡率趋势的现有文献.
- 对观察到的癌症类型及其在壮病患者中增加的频率的分析.
- 识别有关癌症查,风险因素和管理的知识差距.
主要成果:
- 癌症已经成为壮症死亡的主要原因,超过了心血管疾病.
- 长期暴露于增长激素水平升高与癌症发生和进展的增加有关.
- 缺乏确立的癌症查和壮症风险因素评估指南.
结论:
- 由于死亡率的不断变化,壮症患者需要专注于癌症监测.
- 进一步研究瘤巨症瘤发生机制至关重要.
- 开发国际/国家注册表对于研究癌症影响和验证壮症诊断/治疗策略至关重要.
关键词:
乳房 乳房 乳房科伦·科伦 (Colon Colon) 是指一个结肠.新生体 新生体.前列腺前列腺前列腺查检查 查检查 查检查身体生长因子瘤 (somatotropinomas) 是一种生长因子.甲状腺是什么?甲状腺是什么?更多相关视频
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.4K
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
10.7K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:21Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315